Table III. Comparisons for 749 patients with both pre- and post-treatment values using the Individual Burden of Illness for Depression (IBI-D). Values are means (standard deviation [SD]). Paired t test (within intervention change: exit vs base). P=0.082 (nonsignificant [NS]) for difference in base to exit change between interventions, confirmed by Welch's analysis of variance (ANOVA; P=0.143; NS). n, number.
All | Remitters | Nonremitters | |||||||||||||
Intervention | n | IBI-D Pre | IBI-D Post | IBI-D Change | P | n | IBI-D Pre | IBI-D Post | IBI-D Change | P | n | IBI-D Pre | IBI-D Post | IBI-D Change | P |
Bupropion | 121 | -0.02 (1.07) | -0.67 (1.44) | -0.66 (1.21) | <0.0001 | 26 | -0.58 (1.03) | -2.40 (0.78) | -1.82 (1.12) | <0.0001 | 95 | 0.14 (1.03) | -0.20 (1.19) | -0.34 (1.02) | <0.0001 |
Sertraline | 131 | 0.04 (0.95) | -0.79 (1.43) | -0.83 (1.15) | <0.0001 | 35 | -0.54 (0.93) | -2.50 (0.60) | -1.96 (0.82) | <0.0001 | 96 | 0.25 (0.87) | -0.16 (1.10) | -0.42 (0.97) | <0.0001 |
Venlafaxine | 121 | 0.08 (0.92) | -0.81 (1.35) | -0.89 (1.08) | <0.0001 | 34 | -0.32 (0.79) | -2.22 (0.63) | -1.90 (0.91) | <0.0001 | 87 | 0.24 (0.93) | -0.26 (1.13) | -0.49 (0.86) | <0.0001 |
Cognitive therapy | 32 | -0.12 (0.85) | -1.32 (1.41) | -1.20 (1.46) | <0.0001 | 12 | -0.13 (0.94) | -2.68 (0.44) | -2.55 (1.07) | <0.0001 | 20 | -0.11 (0.82) | -0.50 (1.12) | -0.39 (0.99) | <0.0001 |
Citalopram + Bupropion | 148 | -0.34 (0.94) | -1.14 (1.35) | -0.80 (1.09) | <0.0001 | 53 | -0.77 (0.77) | -2.40 (0.64) | -1.64 (0.88) | <0.0001 | 95 | -0.11 (0.95) | -0.44 (1.11) | -0.33 (0.91) | <0.0001 |
Citalopram + Buspirone | 149 | -0.30 (0.98) | -0.90 (1.42) | -0.59 (1.07) | <0.0001 | 38 | -0.76 (072) | -2.30 (0.66) | -1.54 (0.90) | <0.0001 | 111 | -0.15 (1.01) | -0.42 (1.29) | -0.27 (0.93) | <0.0001 |
Citalopram + Cognitive therapy | 47 | -0.14 (0.86) | -0.86 (1.09) | -0.72 (1.14) | <0.0001 | 10 | -032 (0.73) | -2.22 (049) | -1.90 (0.79) | <0.0001 | 37 | -0.10 (0.89) | -0.49 (0.90) | -0.40 (1.01) | <0.0001 |
All | 749 |